Q2 2017 Holdings
Filed 2017-08-14 | 120 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $720.1M | 25,819,768 | 45.1% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $536.4M | 5,905,673 | 33.6% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $165.3M | 3,673,175 | 10.4% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $65.1M | 11,716,784 | 4.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $48.6M | 1,751,463 | 3.0% |
| Cerus Corporation(CERS) | COM | 157085101 | $25.7M | 10,241,943 | 1.6% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $14.1M | 5,102,153 | 0.9% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $6.6M | 128,666 | 0.4% |
| Incyte Corporation(INCY) | COM | 45337C102 | $4.3M | 34,130,161 | 0.3% |
| Seattle Genetics, Inc. | COM | 812578102 | $2.4M | 45,725,556 | 0.1% |
| argenx SE(ARGX) | SPONSORED ADR ADDED | 04016X101 | $2.1M | 100,000 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.3M | 50,000 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.0M | 8,553,864 | 0.1% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $650.0K | 180,582 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $449.0K | 100,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $448.5K | 13,779,866 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $196.7K | 5,509,560 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $153.8K | 10,934,154 | 0.0% |
| Achaogen, Inc. | COM | 004449104 | $104.4K | 4,804,604 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $91.4K | 22,669,509 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | $86.7K | 2,221,706 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $78.8K | 1,318,341 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $69.7K | 7,288,300 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $58.8K | 5,032,313 | 0.0% |
| AveXis, Inc. | COM | 05366U100 | $51.4K | 625,000 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $51.3K | 2,082,012 | 0.0% |
| Novavax, Inc. | NOTE 3.75% 2/1/2023 | 670002AB0 | $46.4K | $108,500,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $38.6K | 2,783,569 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $36.2K | 4,113,376 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $31.7K | 301,441 | 0.0% |
| Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | $30.0K | $35,083,000 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $29.0K | 1,660,593 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $28.4K | 616,682 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $21.4K | 3,015,353 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $21.4K | 3,150,808 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $20.3K | 1,581,424 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $19.9K | 259,894 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $18.4K | 872,072 | 0.0% |
| Merus N.V. | COM | N5749R100 | $18.4K | 1,160,014 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $17.7K | 10,294,970 | 0.0% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $17.1K | 571,667 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $17.0K | 1,062,120 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $16.6K | 208,328 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $15.7K | 299,356 | 0.0% |
| La Jolla Pharmaceutical Company(LJPC) | COM PAR $.0001 2 | 503459604 | $15.0K | 504,732 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $13.9K | 673,908 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | $13.5K | $12,228,000 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $13.3K | 1,585,913 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | NOTE 2.0% 8/15/2019 | 00767EAB8 | $11.5K | $14,517,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $11.4K | 2,466,702 | 0.0% |